Literature DB >> 12700918

Long-term follow-up of cancer in neonates and infants: a national survey of 142 patients.

Andrew B Pintér1, Andrew Hock, Pál Kajtár, Ilona Dóber.   

Abstract

To determine the mortality and survival rates, side effects of surgery and adjuvant chemo- and radiotherapy, somatic development, and fertility, the data of 142 patients under the age of 1 year operated upon for solid malignant tumors from 1975 through 1983 were analyzed. The follow-up period ranged from 16 to 25 years (mean 20); 79 patients survived. The male/female ratio of the survivors was 51/28. Investigations were based on the Hungarian Tumor Registry, personal interviews with the patients and their parents, and detailed questionnaires. Fifty-one patients died, 44 of them before the age of 3 years; 13 were lost to follow-up. Of the 79 survivors, 48 had abdominal and 31 extra-abdominal tumors (35 neuroblastomas, 21 renal tumors, 15 soft-tissue sarcomas, 5 gonadal tumors, 2 sacrococcygeal carcinomas, 1 hepatic tumor). Side effects of surgical intervention included partial urinary incontinence (2), partial fecal incontinence (1), intestinal obstruction (2), nerve injury (1), thorax deformity (4), and scar formation resulting in psychological problems (12). Chemotherapy alone (41 patients) resulted in side effects in 19 patients, radio- and chemotherapy in combination (23) caused side effects in 20. Fifteen patients did not receive adjuvant therapy. The most serious late side effects were 24 spinal deformities, one-half of them severe, breast underdevelopment, muscular deformity, and renal damage. In 19 patients more then one side effect was detected. Height and weight gain decreased ( P < 0.01 and <0.05, respectively) in the first 8-10 years of follow-up and accelerated significantly ( P < 0.05 and <0.05, respectively) in the second half of follow-up. The short follow-up time (16-25 years) permitted only limited analysis of infertility. Whenever possible, surgical excision should be the treatment of choice. No routine aggressive chemotherapy is indicated. Radiation therapy, which frequently results in long-term musculoskeletal morbidity, should be avoided. Catch-up somatic development occurred in the second part of the follow-up period.

Entities:  

Mesh:

Year:  2003        PMID: 12700918     DOI: 10.1007/s00383-002-0760-0

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  31 in total

1.  Second malignant tumors after cancer in childhood.

Authors:  F P Li
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

Review 2.  Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.

Authors:  N Jaffe
Journal:  Pediatr Clin North Am       Date:  1976-02       Impact factor: 3.278

3.  Cancer in neonates: the experience at the Children's Hospital of Philadelphia.

Authors:  G B Gale; G J D'Angio; A Uri; J Chatten; C E Koop
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

4.  Late effects of treatment of cancer in infancy.

Authors:  G Pastore; R Antonelli; W Fine; F P Li; S E Sallan
Journal:  Med Pediatr Oncol       Date:  1982

5.  Neonatal benign sacrococcygeal teratoma may recur in adulthood and give rise to malignancy.

Authors:  P Lahdenne; M Heikinheimo; V Nikkanen; P Klemi; M A Siimes; J Rapola
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

Review 6.  Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment.

Authors:  D Haas; A R Ablin; C Miller; S Zoger; K K Matthay
Journal:  Cancer       Date:  1988-08-15       Impact factor: 6.860

7.  Infants younger than 1 year of age with rhabdomyosarcoma.

Authors:  A H Ragab; R Heyn; M Tefft; D N Hays; W A Newton; M Beltangady
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

8.  Effect of spinal irradiation on growth.

Authors:  S M Shalet; B Gibson; R Swindell; D Pearson
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

Review 9.  Problems in the chemotherapy of cancer in the neonate.

Authors:  S E Siegel; R G Moran
Journal:  Am J Pediatr Hematol Oncol       Date:  1981

10.  Late effects of treatment for Wilms' tumor.

Authors:  P R Thomas; K D Griffith; B B Fineberg; C A Perez; V J Land
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-05       Impact factor: 7.038

View more
  11 in total

Review 1.  A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Authors:  Prasad L Gawade; Melissa M Hudson; Sue C Kaste; Joseph P Neglia; Karen Wasilewski-Masker; Louis S Constine; Leslie L Robison; Kirsten K Ness
Journal:  Curr Pediatr Rev       Date:  2014

2.  Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study.

Authors:  Karen E Kinahan; Lisa K Sharp; Kristy Seidel; Wendy Leisenring; Aarati Didwania; Mario E Lacouture; Marilyn Stovall; Anand Haryani; Leslie L Robison; Kevin R Krull
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

3.  Physical and psychological outcome in long-term survivors of childhood malignant solid tumor in Japan.

Authors:  Nami Honda; Shunichi Funakoshi; Hideo Ambo; Masaki Nio; Yutaka Hayashi; Hiroo Matsuoka
Journal:  Pediatr Surg Int       Date:  2011-02-04       Impact factor: 1.827

4.  Does this chest radiograph belong to a survivor of childhood cancer? Radiographic findings suggesting previous treatment for childhood cancer - a review.

Authors:  Aswin V Kumar; Sue C Kaste
Journal:  J Am Osteopath Coll Radiol       Date:  2014-04

5.  Tinospora cordifolia Induces Differentiation and Senescence Pathways in Neuroblastoma Cells.

Authors:  Rachana Mishra; Gurcharan Kaur
Journal:  Mol Neurobiol       Date:  2014-10-04       Impact factor: 5.590

Review 6.  Late Effects in Survivors of Neonatal Cancer.

Authors:  Sanyukta K Janardan; Karen E Effinger
Journal:  Clin Perinatol       Date:  2021-01-12       Impact factor: 3.430

7.  Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors-A Nationwide Experience.

Authors:  Thomas Blanc; Pierre Meignan; Nicolas Vinit; Quentin Ballouhey; Luca Pio; Carmen Capito; Caroline Harte; Fabrizio Vatta; Louise Galmiche-Rolland; Véronique Minard; Daniel Orbach; Laureline Berteloot; Cécile Muller; Jules Kohaut; Aline Broch; Karim Braik; Aurélien Binet; Yves Heloury; Laurent Fourcade; Hubert Lardy; Sabine Sarnacki
Journal:  Ann Surg Oncol       Date:  2021-09-14       Impact factor: 5.344

8.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

9.  Validation of questionnaire-reported chest wall abnormalities with a telephone interview in Swiss childhood cancer survivors.

Authors:  Rahel Kasteler; Christa Lichtensteiger; Christina Schindera; Marc Ansari; Claudia E Kuehni
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

10.  A 15-year-old Girl with an Asymmetric Hemitruncal Fat Distribution: Hemihyperthrophy or Hemiatrophy?

Authors:  Inge van der Velpen; Pamela Schendelaar; Evelyn van Pinxteren-Nagler; Chantal M Mouës-Vink
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.